BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16390746)

  • 41. [Analysis of salivary testosterone by liquid chromatography-tandem mass spectrometry: correlation with serum bioavailable testosterone and aging].
    Sakaguchi K; Hasegawa T
    Rinsho Byori; 2005 May; 53(5):388-94. PubMed ID: 15966401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analytical and clinical performance of the Ortho-Clinical Diagnostics VITROS amino-terminal pro-B type natriuretic peptide assay.
    Januzzi JL; Lewandrowski KB; Bashirians G; Jackson S; Freyler D; Smith K; Murakami MM; Apple FS
    Clin Chim Acta; 2008 Jan; 387(1-2):48-54. PubMed ID: 17915201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance characteristics of seven automated CA 15-3 assays.
    Slev PR; Rawlins ML; Roberts WL
    Am J Clin Pathol; 2006 May; 125(5):752-7. PubMed ID: 16707378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgen deficiency in women; role of accurate testosterone measurements.
    Demers LM
    Maturitas; 2010 Sep; 67(1):39-45. PubMed ID: 20493647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Radioimmunologic determination of serum testosterone concentration in healthy male probands].
    Rühlmann C; Kellner K
    Z Gesamte Inn Med; 1985 Jan; 40(1):17-9. PubMed ID: 3984413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance characteristics of eight estradiol immunoassays.
    Yang DT; Owen WE; Ramsay CS; Xie H; Roberts WL
    Am J Clin Pathol; 2004 Sep; 122(3):332-7. PubMed ID: 15362362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
    Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
    Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.
    Iwamoto T; Yanase T; Horie H; Namiki M; Okuyama A
    Int J Urol; 2009 Feb; 16(2):168-74. PubMed ID: 19054164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reference ranges for serum and salivary testosterone in young men of Mediterranean region.
    González-Sánchez V; Moreno-Pérez O; García de Guadiana L; Sánchez-Pellicer P; Alfayate R; Mauri M; Sánchez-Payá J; Picó A
    Endocrinol Nutr; 2015 Jan; 62(1):4-10. PubMed ID: 25444977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance of a fully automated fluorometric enzyme immunoassay for serum myoglobin measurement.
    Clerico A; Del Chicca MG; Zucchelli GC; Salutini L; Mercuri A; Scarlattini M
    J Nucl Biol Med (1991); 1993 Jun; 37(2):83-7. PubMed ID: 8373838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance characteristics of five cardiac Troponin I assays.
    La'ulu SL; Roberts WL
    Clin Chim Acta; 2010 Aug; 411(15-16):1095-101. PubMed ID: 20398643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of a high throughput method for serum/plasma testosterone using liquid chromatography tandem mass spectrometry (LC-MS/MS).
    Singh RJ
    Steroids; 2008 Dec; 73(13):1339-44. PubMed ID: 18703076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction.
    Rauh M; Gröschl M; Rascher W; Dörr HG
    Steroids; 2006 Jun; 71(6):450-8. PubMed ID: 16569417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral testosterone in oil: pharmacokinetic effects of 5alpha reduction by finasteride or dutasteride and food intake in men.
    Amory JK; Page ST; Bremner WJ
    J Androl; 2006; 27(1):72-8. PubMed ID: 16400081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA.
    Slev PR; La'ulu SL; Roberts WL
    Am J Clin Pathol; 2008 Jun; 129(6):952-8. PubMed ID: 18480013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amniotic fluid testosterone: relationship with cortisol and gestational age.
    Sarkar P; Bergman K; Fisk NM; O'Connor TG; Glover V
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):743-7. PubMed ID: 17634075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measuring the salivary testosterone and cortisol concentrations of weightlifters using an enzyme-immunoassay kit.
    Crewther BT; Cook C
    Int J Sports Med; 2010 Jul; 31(7):486-9. PubMed ID: 20419618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC-MS/MS method and a 2nd generation automated immunoassay.
    Bui HN; Sluss PM; Blincko S; Knol DL; Blankenstein MA; Heijboer AC
    Steroids; 2013 Jan; 78(1):96-101. PubMed ID: 23127814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial.
    Nakhai-Pour HR; Grobbee DE; Emmelot-Vonk MH; Bots ML; Verhaar HJ; van der Schouw YT
    Am Heart J; 2007 Dec; 154(6):1228.e1-7. PubMed ID: 18035098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.